Login / Signup

Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells.

Carina ForsarePär-Ola BendahlEric MobergCharlotte Levin Tykjær JørgensenSara JanssonAnna-Maria LarssonKristina AaltonenLisa Rydén
Published in: International journal of molecular sciences (2020)
A shift in ER-status from PT to DM/CTCs was demonstrated. ER-positive CTCs during systemic therapy might reflect the retention of a favorable phenotype that still responds to therapy.
Keyphrases
  • circulating tumor cells
  • estrogen receptor
  • circulating tumor
  • breast cancer cells
  • bone marrow
  • glycemic control